▶ 調査レポート

ICSIインジェクションピペットの世界市場2023年:スパイク型、ノンスパイク型

• 英文タイトル:Global ICSI Injection Pipette Market Research Report 2023

QYResearchが調査・発行した産業分析レポートです。ICSIインジェクションピペットの世界市場2023年:スパイク型、ノンスパイク型 / Global ICSI Injection Pipette Market Research Report 2023 / MRC23Q37580資料のイメージです。• レポートコード:MRC23Q37580
• 出版社/出版日:QYResearch / 2023年3月
• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(2-3日)
• 産業分類:消費財
• 販売価格(消費税別)
  Single User¥435,000 (USD2,900)▷ お問い合わせ
  Enterprise License¥870,000 (USD5,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは世界のICSIインジェクションピペット市場について調査・分析し、世界のICSIインジェクションピペット市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析(スパイク型、ノンスパイク型)、用途別セグメント分析(病院、診療所、その他)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Vitrolife、Irvine Scientific、Microtech IVF、Smiths Medical、ART products、BioMedical Instruments、ASTEC Pipette、Optimas、Shivani Scientific、Smiths Medical、KITAZATO CORPORATIONなどが含まれています。世界のICSIインジェクションピペット市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争の影響は、ICSIインジェクションピペット市場規模を推定する際に考慮しました。本レポートは、ICSIインジェクションピペットの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ICSIインジェクションピペットに関するビジネス上の意思決定に役立てることを目的としています。

・ICSIインジェクションピペット市場の概要
- 製品の定義
- ICSIインジェクションピペットのタイプ別セグメント
- 世界のICSIインジェクションピペット市場規模:タイプ別分析(スパイク型、ノンスパイク型)
- ICSIインジェクションピペットの用途別セグメント
- 世界のICSIインジェクションピペット市場規模:用途別分析(病院、診療所、その他)
- 世界のICSIインジェクションピペット市場規模予測(2018年-2029年)
- ICSIインジェクションピペットの平均価格推移(2018年-2029年)
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ICSIインジェクションピペット市場の競争状況およびトレンド

・ICSIインジェクションピペットの地域別市場規模
- 北米のICSIインジェクションピペット市場規模(2018年-2029年)
- アメリカのICSIインジェクションピペット市場規模(2018年-2029年)
- ヨーロッパのICSIインジェクションピペット市場規模(2018年-2029年)
- アジア太平洋のICSIインジェクションピペット市場規模(2018年-2029年)
- 中国のICSIインジェクションピペット市場規模(2018年-2029年)
- 日本のICSIインジェクションピペット市場規模(2018年-2029年)
- 韓国のICSIインジェクションピペット市場規模(2018年-2029年)
- インドのICSIインジェクションピペット市場規模(2018年-2029年)
- オーストラリアのICSIインジェクションピペット市場規模(2018年-2029年)
- 中南米のICSIインジェクションピペット市場規模(2018年-2029年)
- 中東・アフリカのICSIインジェクションピペット市場規模(2018年-2029年)

・タイプ別セグメント:スパイク型、ノンスパイク型
- 世界のICSIインジェクションピペットのタイプ別販売量(2018年-2023年)
- 世界のICSIインジェクションピペットのタイプ別売上(2018年-2023年)
- 世界のICSIインジェクションピペットのタイプ別価格

・用途別セグメント:病院、診療所、その他
- 世界のICSIインジェクションピペットの用途別販売量(2018年-2023年)
- 世界のICSIインジェクションピペットの用途別売上(2018年-2023年)
- 世界のICSIインジェクションピペットの用途別価格

・主要企業のプロファイル:企業情報、事業概要、売上、製品ポートフォリオ、動向
Vitrolife、Irvine Scientific、Microtech IVF、Smiths Medical、ART products、BioMedical Instruments、ASTEC Pipette、Optimas、Shivani Scientific、Smiths Medical、KITAZATO CORPORATION

・産業チェーンと販売チャネルの分析
- ICSIインジェクションピペット産業チェーン分析
- ICSIインジェクションピペットの主要原材料
- ICSIインジェクションピペットの販売チャネル
- ICSIインジェクションピペットのディストリビューター
- ICSIインジェクションピペットの主要顧客

・ICSIインジェクションピペット市場ダイナミクス
- ICSIインジェクションピペットの業界動向
- ICSIインジェクションピペット市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global ICSI Injection Pipette market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for ICSI Injection Pipette is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for ICSI Injection Pipette is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of ICSI Injection Pipette include Vitrolife, Irvine Scientific, Microtech IVF, Smiths Medical, ART products, BioMedical Instruments, ASTEC Pipette, Optimas and Shivani Scientific, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ICSI Injection Pipette, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICSI Injection Pipette.
The ICSI Injection Pipette market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ICSI Injection Pipette market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICSI Injection Pipette manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Vitrolife
Irvine Scientific
Microtech IVF
Smiths Medical
ART products
BioMedical Instruments
ASTEC Pipette
Optimas
Shivani Scientific
Smiths Medical
KITAZATO CORPORATION
Segment by Type
Spiked Types
Non-spiked Types
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ICSI Injection Pipette manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ICSI Injection Pipette in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

レポート目次

1 ICSI Injection Pipette Market Overview
1.1 Product Overview and Scope of ICSI Injection Pipette
1.2 ICSI Injection Pipette Segment by Type
1.2.1 Global ICSI Injection Pipette Market Value Comparison by Type (2023-2029)
1.2.2 Spiked Types
1.2.3 Non-spiked Types
1.3 ICSI Injection Pipette Segment by Application
1.3.1 Global ICSI Injection Pipette Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global ICSI Injection Pipette Market Size Estimates and Forecasts
1.4.1 Global ICSI Injection Pipette Revenue 2018-2029
1.4.2 Global ICSI Injection Pipette Sales 2018-2029
1.4.3 Global ICSI Injection Pipette Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 ICSI Injection Pipette Market Competition by Manufacturers
2.1 Global ICSI Injection Pipette Sales Market Share by Manufacturers (2018-2023)
2.2 Global ICSI Injection Pipette Revenue Market Share by Manufacturers (2018-2023)
2.3 Global ICSI Injection Pipette Average Price by Manufacturers (2018-2023)
2.4 Global ICSI Injection Pipette Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of ICSI Injection Pipette, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ICSI Injection Pipette, Product Type & Application
2.7 ICSI Injection Pipette Market Competitive Situation and Trends
2.7.1 ICSI Injection Pipette Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest ICSI Injection Pipette Players Market Share by Revenue
2.7.3 Global ICSI Injection Pipette Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ICSI Injection Pipette Retrospective Market Scenario by Region
3.1 Global ICSI Injection Pipette Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global ICSI Injection Pipette Global ICSI Injection Pipette Sales by Region: 2018-2029
3.2.1 Global ICSI Injection Pipette Sales by Region: 2018-2023
3.2.2 Global ICSI Injection Pipette Sales by Region: 2024-2029
3.3 Global ICSI Injection Pipette Global ICSI Injection Pipette Revenue by Region: 2018-2029
3.3.1 Global ICSI Injection Pipette Revenue by Region: 2018-2023
3.3.2 Global ICSI Injection Pipette Revenue by Region: 2024-2029
3.4 North America ICSI Injection Pipette Market Facts & Figures by Country
3.4.1 North America ICSI Injection Pipette Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America ICSI Injection Pipette Sales by Country (2018-2029)
3.4.3 North America ICSI Injection Pipette Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe ICSI Injection Pipette Market Facts & Figures by Country
3.5.1 Europe ICSI Injection Pipette Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe ICSI Injection Pipette Sales by Country (2018-2029)
3.5.3 Europe ICSI Injection Pipette Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ICSI Injection Pipette Market Facts & Figures by Country
3.6.1 Asia Pacific ICSI Injection Pipette Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific ICSI Injection Pipette Sales by Country (2018-2029)
3.6.3 Asia Pacific ICSI Injection Pipette Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America ICSI Injection Pipette Market Facts & Figures by Country
3.7.1 Latin America ICSI Injection Pipette Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America ICSI Injection Pipette Sales by Country (2018-2029)
3.7.3 Latin America ICSI Injection Pipette Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ICSI Injection Pipette Market Facts & Figures by Country
3.8.1 Middle East and Africa ICSI Injection Pipette Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa ICSI Injection Pipette Sales by Country (2018-2029)
3.8.3 Middle East and Africa ICSI Injection Pipette Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global ICSI Injection Pipette Sales by Type (2018-2029)
4.1.1 Global ICSI Injection Pipette Sales by Type (2018-2023)
4.1.2 Global ICSI Injection Pipette Sales by Type (2024-2029)
4.1.3 Global ICSI Injection Pipette Sales Market Share by Type (2018-2029)
4.2 Global ICSI Injection Pipette Revenue by Type (2018-2029)
4.2.1 Global ICSI Injection Pipette Revenue by Type (2018-2023)
4.2.2 Global ICSI Injection Pipette Revenue by Type (2024-2029)
4.2.3 Global ICSI Injection Pipette Revenue Market Share by Type (2018-2029)
4.3 Global ICSI Injection Pipette Price by Type (2018-2029)
5 Segment by Application
5.1 Global ICSI Injection Pipette Sales by Application (2018-2029)
5.1.1 Global ICSI Injection Pipette Sales by Application (2018-2023)
5.1.2 Global ICSI Injection Pipette Sales by Application (2024-2029)
5.1.3 Global ICSI Injection Pipette Sales Market Share by Application (2018-2029)
5.2 Global ICSI Injection Pipette Revenue by Application (2018-2029)
5.2.1 Global ICSI Injection Pipette Revenue by Application (2018-2023)
5.2.2 Global ICSI Injection Pipette Revenue by Application (2024-2029)
5.2.3 Global ICSI Injection Pipette Revenue Market Share by Application (2018-2029)
5.3 Global ICSI Injection Pipette Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Vitrolife
6.1.1 Vitrolife Corporation Information
6.1.2 Vitrolife Description and Business Overview
6.1.3 Vitrolife ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Vitrolife ICSI Injection Pipette Product Portfolio
6.1.5 Vitrolife Recent Developments/Updates
6.2 Irvine Scientific
6.2.1 Irvine Scientific Corporation Information
6.2.2 Irvine Scientific Description and Business Overview
6.2.3 Irvine Scientific ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Irvine Scientific ICSI Injection Pipette Product Portfolio
6.2.5 Irvine Scientific Recent Developments/Updates
6.3 Microtech IVF
6.3.1 Microtech IVF Corporation Information
6.3.2 Microtech IVF Description and Business Overview
6.3.3 Microtech IVF ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Microtech IVF ICSI Injection Pipette Product Portfolio
6.3.5 Microtech IVF Recent Developments/Updates
6.4 Smiths Medical
6.4.1 Smiths Medical Corporation Information
6.4.2 Smiths Medical Description and Business Overview
6.4.3 Smiths Medical ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Smiths Medical ICSI Injection Pipette Product Portfolio
6.4.5 Smiths Medical Recent Developments/Updates
6.5 ART products
6.5.1 ART products Corporation Information
6.5.2 ART products Description and Business Overview
6.5.3 ART products ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ART products ICSI Injection Pipette Product Portfolio
6.5.5 ART products Recent Developments/Updates
6.6 BioMedical Instruments
6.6.1 BioMedical Instruments Corporation Information
6.6.2 BioMedical Instruments Description and Business Overview
6.6.3 BioMedical Instruments ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BioMedical Instruments ICSI Injection Pipette Product Portfolio
6.6.5 BioMedical Instruments Recent Developments/Updates
6.7 ASTEC Pipette
6.6.1 ASTEC Pipette Corporation Information
6.6.2 ASTEC Pipette Description and Business Overview
6.6.3 ASTEC Pipette ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ASTEC Pipette ICSI Injection Pipette Product Portfolio
6.7.5 ASTEC Pipette Recent Developments/Updates
6.8 Optimas
6.8.1 Optimas Corporation Information
6.8.2 Optimas Description and Business Overview
6.8.3 Optimas ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Optimas ICSI Injection Pipette Product Portfolio
6.8.5 Optimas Recent Developments/Updates
6.9 Shivani Scientific
6.9.1 Shivani Scientific Corporation Information
6.9.2 Shivani Scientific Description and Business Overview
6.9.3 Shivani Scientific ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shivani Scientific ICSI Injection Pipette Product Portfolio
6.9.5 Shivani Scientific Recent Developments/Updates
6.10 Smiths Medical
6.10.1 Smiths Medical Corporation Information
6.10.2 Smiths Medical Description and Business Overview
6.10.3 Smiths Medical ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Smiths Medical ICSI Injection Pipette Product Portfolio
6.10.5 Smiths Medical Recent Developments/Updates
6.11 KITAZATO CORPORATION
6.11.1 KITAZATO CORPORATION Corporation Information
6.11.2 KITAZATO CORPORATION ICSI Injection Pipette Description and Business Overview
6.11.3 KITAZATO CORPORATION ICSI Injection Pipette Sales, Revenue and Gross Margin (2018-2023)
6.11.4 KITAZATO CORPORATION ICSI Injection Pipette Product Portfolio
6.11.5 KITAZATO CORPORATION Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ICSI Injection Pipette Industry Chain Analysis
7.2 ICSI Injection Pipette Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ICSI Injection Pipette Production Mode & Process
7.4 ICSI Injection Pipette Sales and Marketing
7.4.1 ICSI Injection Pipette Sales Channels
7.4.2 ICSI Injection Pipette Distributors
7.5 ICSI Injection Pipette Customers
8 ICSI Injection Pipette Market Dynamics
8.1 ICSI Injection Pipette Industry Trends
8.2 ICSI Injection Pipette Market Drivers
8.3 ICSI Injection Pipette Market Challenges
8.4 ICSI Injection Pipette Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer